https://news.medxy.ai/zh/%e9%95%bf%e6%9c%9f%e9%81%93%e8%b7%af%e4%ba%a4%e9%80%9a%e5%99%aa%e5%a3%b0%e6%9a%b4%e9%9c%b2%e4%b8%8e%e5%b8%95%e9%87%91%e6%a3%ae%e7%97%85%e9%a3%8e%e9%99%a9%ef%bc%9a%e6%9d%a5%e8%87%aa%e4%b8%b9%e9%ba%a6/Medxy AIzh2026-07-22T17:15:49-07:00长期道路交通噪声暴露与帕金森病风险：来自丹麦全国队列研究的启示 https://news.medxy.ai/ja/60385-2/Medxy AIja2026-07-22T17:15:34-07:00 https://news.medxy.ai/vi/phoi-nhiem-tieng-on-giao-thong-duong-bo-dai-han-va-moi-lien-quan-voi-nguy-co-benh-parkinson-goc-nhin-tu-nghien-cuu-doan-he-toan-quoc-tai-dan-mach/Medxy AIvi2026-07-22T17:15:15-07:00Phơi Nhiễm Tiếng Ồn Giao Thông Đường Bộ Dài Hạn và Mối Liên Quan Với Nguy Cơ Bệnh Parkinson: Góc Nhìn Từ Nghiên Cứu Đoàn Hệ Toàn Quốc Tại Đan Mạch https://news.medxy.ai/long-term-road-traffic-noise-exposure-and-its-association-with-parkinson-disease-risk-insights-from-a-danish-nationwide-cohort-study/Medxy AIen2026-07-22T17:14:33-07:00Long-Term Road Traffic Noise Exposure and Its Association with Parkinson Disease Risk: Insights from a Danish Nationwide Cohort Study https://news.medxy.ai/zh/antithyroid-drug-duration-in-graves-disease/Medxy AIzh2026-07-22T17:13:19-07:00TRAb较低的Graves病患者，抗甲状腺药物疗程能否缩短？证据支持个体化治疗时长 https://news.medxy.ai/ja/optimizing-antithyroid-drug-duration-in-graves-disease/Medxy AIja2026-07-22T17:13:03-07:00TRAb低値のバセドウ病における抗甲状腺薬投与期間の最適化：短期療法の根拠 https://news.medxy.ai/vi/optimizing-antithyroid-drug-duration-in-graves-disease-with-low-trab/Medxy AIvi2026-07-22T17:12:46-07:00Tối ưu hóa thời gian dùng thuốc kháng giáp trong bệnh Graves có TRAb thấp: Bằng chứng ủng hộ liệu trình ngắn hơn https://news.medxy.ai/optimizing-antithyroid-drug-duration-in-graves-disease-with-low-trab-evidence-for-shorter-therapy/Medxy AIen2026-07-22T17:12:05-07:00Optimizing Antithyroid Drug Duration in Graves’ Disease with Low TRAb: Evidence for Shorter Therapy https://news.medxy.ai/zh/mild-cold-with-shivering-lowers-24-hour-glucose-levels-in-t2dm/Medxy AIzh2026-07-22T17:11:16-07:00寒战型轻度寒冷暴露可降低2型糖尿病患者24小时血糖：一种新型辅助治疗 https://news.medxy.ai/ja/mild-cold-exposure-with-shivering-lowers-24-hour-glucose-levels-in-t2dm/Medxy AIja2026-07-22T17:10:59-07:00振戦を伴う軽度寒冷曝露が2型糖尿病の24時間血糖を低下させる：新しい補助療法の可能性 https://news.medxy.ai/vi/mild-cold-exposure-with-shivering-lowers-24-hour-glucose-levels-in-type-2-diabetes/Medxy AIvi2026-07-22T17:10:39-07:00Phơi nhiễm lạnh nhẹ gây run cơ giúp giảm glucose 24 giờ ở đái tháo đường type 2: một liệu pháp hỗ trợ mới https://news.medxy.ai/mild-cold-exposure-with-shivering-lowers-24-hour-glucose-levels-in-type-2-diabetes-a-novel-adjunctive-therapy/Medxy AIen2026-07-22T17:09:57-07:00Mild Cold Exposure with Shivering Lowers 24-Hour Glucose Levels in Type 2 Diabetes: A Novel Adjunctive Therapy https://news.medxy.ai/ja/oral-semaglutide-and-cardiovascular-benefits/Medxy AIja2026-07-22T14:28:16-07:00SOUL試験でみた経口セマグルチドの心血管ベネフィット：ベースラインHbA1c・BMIとその変化が臨床転帰に及ぼす影響 https://news.medxy.ai/vi/oral-semaglutide-and-cardiovascular-benefits-in-the-soul-trial/Medxy AIvi2026-07-22T14:27:57-07:00Semaglutide đường uống và lợi ích tim mạch trong thử nghiệm SOUL: Ảnh hưởng của HbA1c và BMI nền cũng như sự thay đổi của chúng đến kết cục lâm sàng https://news.medxy.ai/oral-semaglutide-and-cardiovascular-benefits-in-the-soul-trial-impact-of-baseline-and-changes-in-hba1c-and-bmi-on-clinical-outcomes/Medxy AIen2026-07-22T14:27:06-07:00Oral Semaglutide and Cardiovascular Benefits in the SOUL Trial: Impact of Baseline and Changes in HbA1c and BMI on Clinical Outcomes https://news.medxy.ai/zh/bmi-normalization-reduces-risk-of-t1dm-2/Medxy AIzh2026-07-22T11:52:47-07:00BMI正常化显著降低青少年1型糖尿病进展风险 https://news.medxy.ai/ja/bmi-normalization-reduces-risk-of-t1dm/Medxy AIja2026-07-22T11:52:03-07:00若年の1型糖尿病進行、BMI正常化で大幅に抑制 https://news.medxy.ai/vi/bmi-normalization-significantly-reduces-risk-of-t1dm/Medxy AIvi2026-07-22T11:51:42-07:00Bình thường hóa BMI giúp giảm đáng kể nguy cơ tiến triển đái tháo đường type 1 ở người trẻ https://news.medxy.ai/bmi-normalization-significantly-reduces-risk-of-type-1-diabetes-progression-in-youth/Medxy AIen2026-07-22T11:50:50-07:00BMI Normalization Significantly Reduces Risk of Type 1 Diabetes Progression in Youth https://news.medxy.ai/ja/glp-1-receptor-agonists-a-breakthrough-in-reducing-atherosclerosis-and-cardiovascular-risk/Medxy AIja2026-07-22T08:44:37-07:00GLP-1受容体作動薬：糖尿病や肥満を超えて、動脈硬化と心血管リスクを低減する新たな展開 https://news.medxy.ai/glp-1-receptor-agonists-a-breakthrough-in-reducing-atherosclerosis-and-cardiovascular-risk-beyond-diabetes-and-obesity/Medxy AIen2026-07-22T08:42:08-07:00GLP-1 Receptor Agonists: A Breakthrough in Reducing Atherosclerosis and Cardiovascular Risk Beyond Diabetes and Obesity https://news.medxy.ai/zh/exposure-to-pm2-5-constituents-and-chd-risk/Medxy AIzh2026-07-21T15:22:15-07:00长期暴露于PM2.5与冠心病风险的关系 https://news.medxy.ai/ja/exposure-to-pm2-5-constituents-and-coronary-heart-disease-risk/Medxy AIja2026-07-21T15:21:45-07:00中国におけるPM2.5成分の長期曝露と冠動脈疾患リスク：包括的レビュー https://news.medxy.ai/vi/long-term-exposure-to-pm2-5-constituents-and-coronary-heart-disease-risk/Medxy AIvi2026-07-21T15:21:09-07:00Phơi nhiễm dài hạn với các thành phần PM2.5 và nguy cơ bệnh mạch vành ở Trung Quốc: Tổng quan toàn diện https://news.medxy.ai/long-term-exposure-to-pm2-5-constituents-and-coronary-heart-disease-risk-in-china-a-comprehensive-review/Medxy AIen2026-07-21T15:19:42-07:00Long-Term Exposure to PM2.5 Constituents and Coronary Heart Disease Risk in China: A Comprehensive Review https://news.medxy.ai/zh/medically-tailored-groceries-on-glycemic-control-in-adults-with-t2dm/Medxy AIzh2026-07-21T15:14:22-07:00医嘱定制食品杂货对 Medicaid 承保2型糖尿病成人血糖控制的影响：随机对照试验带来的启示 https://news.medxy.ai/ja/medically-tailored-groceries-on-glycemic-control-in-adults-with-type-2-diabetes/Medxy AIja2026-07-21T15:13:52-07:00Medicaid加入の2型糖尿病成人における血糖管理への医療的に調整された食料品の影響：ランダム化比較試験からの知見 https://news.medxy.ai/vi/medically-tailored-groceries-on-glycemic-control-in-medicaid-insured-adults-with-type-2-diabetes/Medxy AIvi2026-07-21T15:13:17-07:00Tác động của các gói thực phẩm được thiết kế theo nhu cầu y tế đối với việc kiểm soát đường huyết ở người trưởng thành mắc đái tháo đường tuýp 2 có bảo hiểm Medicaid https://news.medxy.ai/impact-of-medically-tailored-groceries-on-glycemic-control-in-medicaid-insured-adults-with-type-2-diabetes-insights-from-a-randomized-controlled-trial/Medxy AIen2026-07-21T15:12:05-07:00Impact of Medically Tailored Groceries on Glycemic Control in Medicaid-Insured Adults with Type 2 Diabetes: Insights from a Randomized Controlled Trial https://news.medxy.ai/zh/digital-standardized-skin-care-enhances-outcomes-in-patients-with-acne-rosacea-comorbidity/Medxy AIzh2026-07-21T14:56:11-07:00数字化标准化皮肤护理方案可改善痤疮合并玫瑰痤疮患者结局：一项真实世界纵向队列研究 https://news.medxy.ai/ja/digital-standardized-skin-care-regimen-enhances-outcomes-in-patients-with-acne-rosacea/Medxy AIja2026-07-21T14:55:52-07:00ニキビ・酒さ併存に対するデジタル標準化スキンケアが奏効：リアルワールド縦断コホートからの知見 https://news.medxy.ai/vi/digital-standardized-skin-care-regimen-enhances-outcomes-in-patients-with-acne-rosacea-comorbidity/Medxy AIvi2026-07-21T14:55:28-07:00Phác đồ chăm sóc da chuẩn hóa kỹ thuật số cải thiện kết cục ở bệnh nhân đồng mắc mụn trứng cá – rosacea: bằng chứng từ một đoàn hệ theo dõi dọc trong thực tế https://news.medxy.ai/digital-standardized-skin-care-regimen-enhances-outcomes-in-patients-with-acne-rosacea-comorbidity-insights-from-a-real-world-longitudinal-cohort/Medxy AIen2026-07-21T14:54:42-07:00Digital Standardized Skin Care Regimen Enhances Outcomes in Patients with Acne-Rosacea Comorbidity: Insights from a Real-World Longitudinal Cohort https://news.medxy.ai/zh/carotid-artery-depth-for-safe-hemostatic-net-use-in-surgery/Medxy AIzh2026-07-21T14:49:10-07:00颈动脉有多深？面部拉皮术中安全使用止血网的解剖学依据 https://news.medxy.ai/ja/carotid-artery-depth-for-safe-hemostatic-net-use-in-facelift-surgery/Medxy AIja2026-07-21T14:48:53-07:00その下に潜むもの：フェイスリフト手術で止血ネットを安全に用いるための頸動脈深度の読み解き https://news.medxy.ai/vi/navigating-carotid-artery-depth-for-safe-hemostatic-net-use-in-facelift-surgery/Medxy AIvi2026-07-21T14:48:33-07:00Bên dưới bề mặt: Xác định độ sâu động mạch cảnh để sử dụng lưới cầm máu an toàn trong phẫu thuật căng da mặt https://news.medxy.ai/what-lies-beneath-navigating-carotid-artery-depth-for-safe-hemostatic-net-use-in-facelift-surgery/Medxy AIen2026-07-21T14:47:46-07:00What Lies Beneath: Navigating Carotid Artery Depth for Safe Hemostatic Net Use in Facelift Surgery https://news.medxy.ai/zh/dorsal-preservation-rhinoplasty-2/Medxy AIzh2026-07-21T12:05:56-07:00鼻背保留隆鼻术解析：逾千例病例带来的分类与实践启示 https://news.medxy.ai/ja/dorsal-preservation-rhinoplasty/Medxy AIja2026-07-21T12:05:37-07:001,191例から読み解く鼻背温存鼻形成術：発展、分類、そして最適化の要点 https://news.medxy.ai/vi/dorsal-preservation-rhinoplasty-insights-and-classification-from-over-a-thousand-cases/Medxy AIvi2026-07-21T12:05:17-07:00Làm rõ về phẫu thuật nâng mũi bảo tồn sống mũi: Những hiểu biết và phân loại từ hơn một nghìn ca lâm sàng https://news.medxy.ai/clarifying-dorsal-preservation-rhinoplasty-insights-and-classification-from-over-a-thousand-cases/Medxy AIen2026-07-21T12:04:21-07:00Clarifying Dorsal Preservation Rhinoplasty: Insights and Classification from Over a Thousand Cases https://news.medxy.ai/zh/2-year-psychiatric-and-neurologic-risks-after-infections/Medxy AIzh2026-07-21T10:43:03-07:00因感染住院后2年内精神与神经系统风险的图谱 https://news.medxy.ai/ja/2-year-psychiatric-and-neurologic-risks-after-infections-across-body-systems-and-age-groups/Medxy AIja2026-07-21T10:42:40-07:00感染症後2年間の精神・神経学的リスクを身体系・年齢層別に可視化する：統合的レビュー https://news.medxy.ai/vi/mapping-2-year-psychiatric-and-neurologic-risks-after-infections-across-body-systems-and-age-groups/Medxy AIvi2026-07-21T10:42:16-07:00Lập bản đồ nguy cơ tâm thần và thần kinh trong 2 năm sau nhiễm trùng theo hệ cơ quan và nhóm tuổi: Tổng quan tích hợp https://news.medxy.ai/mapping-2-year-psychiatric-and-neurologic-risks-after-infections-across-body-systems-and-age-groups-an-integrative-review/Medxy AIen2026-07-21T10:41:00-07:00Mapping 2-Year Psychiatric and Neurologic Risks After Infections Across Body Systems and Age Groups: An Integrative Review https://news.medxy.ai/zh/tissue-hypoperfusion-with-vasopressor-in-refractory-septic-shock/Medxy AIzh2026-07-21T10:40:38-07:00联合组织低灌注标志物与血管活性药物剂量，可提升难治性脓毒性休克死亡风险分层 https://news.medxy.ai/ja/tissue-hypoperfusion-markers-with-vasopressor-dose-in-refractory-septic-shock/Medxy AIja2026-07-21T10:40:17-07:00組織低灌流マーカーと昇圧薬投与量の併用で、難治性敗血症性ショックの死亡リスク層別化が向上 https://news.medxy.ai/vi/tissue-hypoperfusion-markers-with-vasopressor-dose-enhances-mortality-risk-stratification-in-refractory-septic-shock/Medxy AIvi2026-07-21T10:39:49-07:00Kết hợp dấu ấn giảm tưới máu mô với liều thuốc vận mạch giúp tăng độ chính xác phân tầng nguy cơ tử vong trong sốc nhiễm khuẩn kháng trị https://news.medxy.ai/combining-tissue-hypoperfusion-markers-with-vasopressor-dose-enhances-mortality-risk-stratification-in-refractory-septic-shock/Medxy AIen2026-07-21T10:38:50-07:00Combining Tissue Hypoperfusion Markers with Vasopressor Dose Enhances Mortality Risk Stratification in Refractory Septic Shock https://news.medxy.ai/zh/decannulation-success-in-neurologic-patients-with-abdominal-electrical-stimulation/Medxy AIzh2026-07-21T10:38:10-07:00腹部电刺激助力神经系统疾病患者成功拔管：联合气道廓清技术的临床价值 https://news.medxy.ai/ja/decannulation-success-in-neurologic-patients-the-role-of-abdominal-electrical-stimulation/Medxy AIja2026-07-21T10:37:53-07:00神経疾患患者における気管カニューレ抜去の成功率向上：気道クリアランス手技と腹部電気刺激の併用による役割 https://news.medxy.ai/vi/enhancing-decannulation-success-in-neurologic-patients-the-role-of-abdominal-electrical-stimulation/Medxy AIvi2026-07-21T10:37:34-07:00Tăng tỷ lệ rút canuyn thành công ở bệnh nhân thần kinh: Vai trò của kích thích điện bụng kết hợp kỹ thuật làm sạch đường thở https://news.medxy.ai/enhancing-decannulation-success-in-neurologic-patients-the-role-of-abdominal-electrical-stimulation-combined-with-airway-clearance-techniques/Medxy AIen2026-07-21T10:36:43-07:00Enhancing Decannulation Success in Neurologic Patients: The Role of Abdominal Electrical Stimulation Combined With Airway Clearance Techniques https://news.medxy.ai/zh/awake-intubation-in-emergency/Medxy AIzh2026-07-21T10:33:03-07:00急诊清醒插管的十年回顾：发生率、技术与结局 https://news.medxy.ai/ja/awake-intubation-in-emergency-settings/Medxy AIja2026-07-21T10:32:49-07:00救急現場における覚醒下挿管：気道レジストリ10年解析からみた発生頻度・手技・転帰 https://news.medxy.ai/vi/awake-intubation-in-emergency-settings-incidence-techniques-and-outcomes/Medxy AIvi2026-07-21T10:32:04-07:00Đặt nội khí quản khi bệnh nhân còn tỉnh trong cấp cứu: Tần suất, kỹ thuật và kết cục từ dữ liệu đăng ký đường thở trong 10 năm https://news.medxy.ai/awake-intubation-in-emergency-settings-incidence-techniques-and-outcomes-from-a-decade-of-airway-registries/Medxy AIen2026-07-21T10:31:16-07:00Awake Intubation in Emergency Settings: Incidence, Techniques, and Outcomes from a Decade of Airway Registries https://news.medxy.ai/zh/opioid-use-disorder-and-overdose-risk-in-older-adults/Medxy AIzh2026-07-21T10:08:09-07:00老年人阿片类药物使用障碍与过量风险预测：预后模型评估 https://news.medxy.ai/ja/opioid-use-disorder-and-overdose-risk-in-older-adults-evaluating-prognostic-models/Medxy AIja2026-07-21T10:07:52-07:00高齢者のオピオイド使用障害と過量投与リスクを予測する：予後予測モデルの評価 https://news.medxy.ai/vi/predicting-opioid-use-disorder-and-overdose-risk-in-older-adults/Medxy AIvi2026-07-21T10:07:31-07:00Dự đoán nguy cơ rối loạn sử dụng opioid và quá liều ở người cao tuổi: Đánh giá các mô hình tiên lượng https://news.medxy.ai/predicting-opioid-use-disorder-and-overdose-risk-in-older-adults-evaluating-prognostic-models/Medxy AIen2026-07-21T10:06:40-07:00Predicting Opioid Use Disorder and Overdose Risk in Older Adults: Evaluating Prognostic Models